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Abstracts / Urological Science 26 (2015) S1eS25S14cell line: PC3 and human breast cancer cell line: MCF-7 were used in this
study. Inhibition of basal autophagy was achieved using CQ, HCQ and
Baﬁlomycin A1 (Baf A1) in multiple human bladder cancer cell lines. Cell
viability was assessed byWST-1 assay.Western blot detection of LC3-II was
performed to monitor autophagy, while detection of caspase 3/7 activities
and DNA fragmentationwere conducted to investigate apoptotic induction
in treated cells. The disruption of mitochondria membrane potential
(MMP), the generation of reactive oxygen species (ROS) and lysosome
permeability were accessed by JC-1, H2DCFDA staining and IF detection of
cathepsin D and E, respectively, in CQ- and HCQ-treated cells.
Results: Changes in LC3 ﬂux, monitored by Western blot and IF, indicated
inhibition of autophagy at the level of the autophagosome by CQ and HCQ.
Both two autophagy inhibitors induced cytotoxicity in multiple human
bladder cell lines in time- and dose-dependent manner especially in
advanced cancer cell lines. CQ and HCQ also signiﬁcantly impacted the
clonogenic formation of bladder cancer cells. However, the inhibition of
cell viability was only observed in bladder cancer cell lines but not in SV-
Huc-1, PC3 and MCF-7 cells that reported to be with low basal autophagy
activity. Induction of apoptosis was found in cells treated with CQ and
HCQ. We cannot detected the disruption of mitochondria membrane po-
tential nor the generation of reactive oxygen species in CQ- or HCQ-treated
cells. Translocation of cathepsin B in CQ-treated cells suggesting the
change of lysosome permeability that leads to the blockage of autophagy
and increasing apoptotic cell death by these agents.
Conclusion: Targeting autophagy with CQ or HCQ may be an effective
cancer therapy in human bladder cancer.
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Purpose: Benzyl isothiocyanate (BITC) is contained in cruciferous plants
which are part of the human diet, and has been shown to induce apoptosis
in varies cancer cell lines including human bladder cancer cells. In our
previous work, we showed that BITC induces protective autophagy via
inhibition of mTOR signaling pathway in prostate cancer cells. And the
induced apoptosis and autophagy in human prostate cancer cells were
mediated by BITC-induced ROS generation. Here we investigated weather
inhibition of autophagy enhances apoptosis in human bladder cancer cells
as a novel therapeutic strategy.
Materials and Methods: Human bladder cancer cell lines including
grade II, 5637, and grad III, T24, were used in this study. We also included
mouse bladder cancer cell line, MBT2, for the development of orthotopic
mice bladder cancer model for further study. Baﬁlomycin A1 (Baf A1) and
chloroquine (CQ) were used as autophagy inhibitors. Cell viability in
BITC-treated cells with or without the pretreatment of autophagy in-
hibitors were measured by WST-1 reagent. Detection of autophagy was
conducted by measuring the LC3-II processing and the accumulation of
p62 by Western blotting and immunoﬂuorescent staining of these
marker protein. Detection of apoptosis was performed by the monitored
the caspase 3/7 activity, Western blot of cleavage caspase3 and cell
ﬂowcytometry of DNA fragmentation in treated cells. Detection of
autophagy was conducted by measuring the LC3-II processing and the
accumulation of p62.
Results: Exposure of 5637, T24 and MBT2 cells to pharmacologic concen-
trations of BITC resulted in the decrease of cell viability and autophagy
induction. Although inhibition of basal autophagy by Baf A1 or CQ alone
caused cell viability loss in these bladder cancer cell lines, pre-treatment of
Baf A1 or CQ to inhibit BITC-induced autophagy further enhanced the in-
hibition of cell growth. Enhanced apoptosis judged by the increased cas-
pase 3/7 activity, increased amount of cleaved caspase 3 and elevated level
of DNA fragmentation in BITC-treated cell with Baf A1 or CQ pretreatment
suggesting inhibition of autophagy signiﬁcantly potentiates the anti-can-
cer effect of BITC in human bladder cancer cells.Conclusion: This is the ﬁrst study showed that inhibition of autophagy
induced by BITC markedly enhance apoptosis in human and mouse
bladder cancer cells. We are currently using orthotopic mice bladder
cancer model to translate our results from in vitro to in vivo studies. Our
data may be beneﬁcial for further development of novel therapeutic
strategies against bladder cancer.
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Purpose: The identiﬁcation of potential tumor markers will help improve
therapeutic planning and patient management. Thrombomodulin (TM) is a
sensitive urothelial marker. TM was reported to be one of the endogenous
anti-metastatic factors and has diagnostic and prognostic values for the
progression of carcinoma. In the present study, we examine the role of TM
in bladder cancer.
Materials and Methods:We studied the role of TM in tumor behavior and
related signaling pathways in vitro using the human bladder cancer cell
lines HT1376, HT1197, J82 and T24, and in vivo using animal models. We
also selected clinical specimens from 100 patients with bladder cancer for
immunohistochemical staining to evaluate the predictive capacity of TM in
tumor invasiveness.
Results: The data revealed that positive immunoreactivity for TM was
inversely correlated with clinical stage and DNA methyltransferase 1
immunoreactivity. Decreased TM expression could predict the aggressive
tumor growth and advanced clinical stage in bladder cancer.When TMwas
inhibited, tumor growth rate and invasion ability were augmented in vitro
and in vivo. The underlying changes included increased cell proliferation,
enhanced epithelial-mesenchymal transition (EMT) and angiogenesis.
Moreover, inhibition of NF-kB activation signiﬁcantly increased TM
expression and attenuated tumor aggressiveness in bladder cancer.
Conclusion: TM plays an important role in bladder cancer tumor aggres-
siveness in vitro and in vivo and is a clinically signiﬁcant predictor that
may represent a suitable therapeutic target for bladder cancer.Podium-8
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Purpose: To investigate the prognostic factors for bladder recurrence after
radical nephroureterectomy (RNU) in patients with upper urinary tract
urothelial carcinoma (UUT-UC)
Materials and Methods: From 1994 to 2012, 695 patients with UUT-UC
treated with RNU were enrolled in National Taiwan University Medical
Center. Among them, 532 patients with no prior bladder UC histories were
recruited for analysis. We assessed the impact of potentially prognostic
factors on bladder recurrence after RNU.
Results: The median follow-up period was 47.8 months. In the Cox model,
ureteral involvement and diabetes mellitus (DM) were signiﬁcantly asso-
ciated with a higher bladder recurrence rate in the multivariate analysis
(hazard ratio [HR]: 1.838; p¼ 0.003 and HR: 1.821; p¼ 0.010, respectively).
In the Kaplan-Meier analysis, DM patients with concomitant ureteral UC
